Forte Biosciences (FBRX) Misses Q2 EPS by 96c

Forte Biosciences (NASDAQ: FBRX) reported Q2 EPS of ($0.96).

For earnings history and earnings-related data on Forte Biosciences (FBRX) click here.

You May Also Be Interested In

• SanDisk upgraded at JPMorgan after investor day; shares climb
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Wolverine World Wide (WWW) PT Raised to $31 at UBS on Growth, EPS Upside Potential